Javed Ali Selected Research

nerolidol

12/2020	Nano-engineered nerolidol loaded lipid carrier delivery system attenuates cyclophosphamide neurotoxicity - Probable role of NLRP3 inflammasome and caspase-1.
11/2020	Nerolidol protects the liver against cyclophosphamide-induced hepatic inflammation, apoptosis, and fibrosis via modulation of Nrf2, NF-κB p65, and caspase-3 signaling molecules in Swiss albino mice.
11/2019	Nerolidol attenuates cyclophosphamide-induced cardiac inflammation, apoptosis and fibrosis in Swiss Albino mice.
11/2019	Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: Plausible role of Nrf2 and NF- κB.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javed Ali Research Topics

Disease

18	Parkinson Disease (Parkinson's Disease) 04/2022 - 03/2011
14	Neoplasms (Cancer) 12/2022 - 01/2010
9	Inflammation (Inflammations) 01/2022 - 06/2010
9	Nervous System Diseases (Neurological Disorders) 11/2021 - 01/2010
8	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2012
7	Cognitive Dysfunction 12/2022 - 11/2019
7	Edema (Dropsy) 01/2022 - 09/2007
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 03/2011
6	Neuroinflammatory Diseases 12/2022 - 01/2019
6	Skin Neoplasms (Skin Cancer) 12/2021 - 01/2019
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2010
5	Myocardial Infarction 01/2022 - 01/2015
5	Body Weight (Weight, Body) 01/2021 - 01/2015
4	Hypertension (High Blood Pressure) 01/2022 - 02/2010
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2020
4	Catalepsy 11/2021 - 02/2013
4	Infections 01/2021 - 07/2012
4	Cardiotoxicity 01/2021 - 01/2015
4	Osteoporosis 01/2020 - 01/2015
3	Glioblastoma (Glioblastoma Multiforme) 12/2022 - 01/2021
3	Schizophrenia (Dementia Praecox) 12/2022 - 01/2019
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 07/2011
3	Fibrosis (Cirrhosis) 11/2020 - 01/2016
2	HIV Infections (HIV Infection) 01/2022 - 01/2021
2	Dementia (Dementias) 11/2021 - 01/2020
2	Glioma (Gliomas) 01/2020 - 01/2016
2	Wounds and Injuries (Trauma) 01/2020 - 10/2013
2	Huntington Disease (Huntington's Disease) 01/2020 - 01/2020
2	Rheumatoid Arthritis 02/2019 - 01/2009
2	Communicable Diseases (Infectious Diseases) 01/2018 - 04/2009
2	Glaucoma 01/2018 - 04/2014
2	Cough 05/2010 - 01/2010
2	Osteoarthritis 09/2009 - 07/2008
2	Pain (Aches) 01/2009 - 01/2007
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022

Drug/Important Bio-Agent (IBA)

26	Pharmaceutical PreparationsIBA 09/2022 - 01/2010
13	LipidsIBA 12/2022 - 01/2016
9	AntioxidantsIBA 01/2021 - 01/2015
7	ResveratrolIBA 09/2022 - 12/2014
7	Haloperidol (Haldol)FDA LinkGeneric 11/2021 - 02/2013
6	Proteins (Proteins, Gene)FDA Link 12/2021 - 05/2010
6	EnzymesIBA 12/2021 - 01/2015
6	ChitosanIBA 01/2021 - 06/2014
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 02/2019
5	CarrageenanIBA 01/2021 - 09/2007
4	Glutathione (Reduced Glutathione)IBA 04/2022 - 10/2018
4	SuspensionsIBA 01/2022 - 01/2015
4	Liposomes (Liposome)IBA 01/2022 - 06/2010
4	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2022 - 01/2015
4	Caspase 3 (Caspase-3)IBA 12/2021 - 01/2015
4	Alendronate (Alendronate Sodium)FDA LinkGeneric 11/2021 - 01/2019
4	SolutionsIBA 01/2021 - 01/2009
4	CurcuminIBA 01/2021 - 01/2010
4	nerolidolIBA 12/2020 - 11/2019
3	Biological ProductsIBA 12/2022 - 01/2010
3	Free RadicalsIBA 04/2022 - 10/2018
3	PolymersIBA 12/2021 - 05/2010
3	Diphosphonates (Bisphosphonates)IBA 11/2021 - 01/2015
3	Thiobarbituric Acid Reactive SubstancesIBA 11/2021 - 10/2018
3	CatalaseIBA 11/2021 - 01/2019
3	CytokinesIBA 01/2021 - 05/2011
3	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2016
3	Peptides (Polypeptides)IBA 01/2021 - 05/2010
3	Superoxide DismutaseIBA 01/2021 - 10/2018
3	Vitamin E FDA LinkGeneric 01/2019 - 12/2014
3	Dopamine (Intropin)FDA LinkGeneric 10/2018 - 01/2015
2	Antipsychotic Agents (Antipsychotics)IBA 12/2022 - 12/2019
2	Bromocriptine (Parlodel)FDA LinkGeneric 04/2022 - 01/2021
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 08/2016
2	CalciumIBA 01/2022 - 02/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 01/2021
2	Interleukin-1beta (Interleukin 1 beta)IBA 12/2021 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 12/2021 - 06/2021
2	Nanoparticle Drug Delivery SystemIBA 12/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2015
2	Amyloid beta-PeptidesIBA 11/2021 - 01/2021
2	Cholinergic Agents (Cholinergics)IBA 11/2021 - 01/2019
2	ropinirole (Requip)FDA LinkGeneric 01/2021 - 06/2015
2	Dosage Forms (Dosage Form)IBA 01/2021 - 06/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2021
2	QuercetinIBA 01/2021 - 09/2020
2	NF-kappa B (NF-kB)IBA 01/2021 - 02/2019
2	HydrogelsIBA 12/2020 - 07/2011
2	CollagenIBA 11/2020 - 01/2020
2	Selegiline (E250)FDA LinkGeneric 10/2018 - 10/2016
2	EdaravoneIBA 08/2016 - 01/2015
2	benidipineIBA 08/2016 - 01/2015
2	TabletsIBA 06/2010 - 01/2009
2	Celecoxib (Celebrex)FDA Link 09/2009 - 07/2008
2	aceclofenacIBA 01/2009 - 12/2007
1	Tuberculin (PPD)IBA 12/2022
1	Paliperidone Palmitate FDA Link 12/2022
1	Temozolomide (Temodar)FDA LinkGeneric 09/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Isradipine (Dynacirc)FDA LinkGeneric 01/2022

Therapy/Procedure

21	Therapeutics 01/2022 - 04/2009
6	Drug Therapy (Chemotherapy) 12/2022 - 01/2020
3	Radiotherapy 12/2022 - 01/2020
2	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 01/2021